Patents by Inventor Julius FREDENS

Julius FREDENS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158736
    Abstract: The invention relates to prokaryotic cells for the production of polymers containing non-canonical amino acids, and to methods for making said cells. The invention also relates to newly obtainable polymers as produced by the cells of the invention. In addition, the invention relates to new orthogonal aminoacyl-tRNA synthetases (aaRSs) and orthogonal tRNAs, which may be used in pairs and find utility in host cells such as, but not limited to, the prokaryotic cells of the invention.
    Type: Application
    Filed: November 8, 2023
    Publication date: May 16, 2024
    Inventors: Wesley E. ROBERTSON, Louise F. H. FUNKE, Daniel DE LA TORRE, Julius FREDENS, Thomas S. ELLIOTT, Daniel L. DUNKELMANN, Julian C.W. WILLIS, Adam T. BEATTIE, Jason W. CHIN
  • Publication number: 20240132874
    Abstract: The current invention provides a synthetic prokaryotic genome comprising 5 or fewer occurrences of one or more sense codons; and/or a synthetic prokaryotic genome derived from a parent genome, wherein the synthetic prokaryotic genome comprises less than 10%, 5%, 2%, 1%, 0.5%, 0.1% of the occurrences of one or more sense codons, relative to the parent genome; and/or a synthetic prokaryotic genome comprising 100 or more, 200 or more, or 1000 or more genes with no occurrences of one or more sense codons.
    Type: Application
    Filed: October 23, 2023
    Publication date: April 25, 2024
    Inventors: Julius FREDENS, Kaihang WANG, Daniel DE LA TORRE, Louise F. H. FUNKE, Wesley E. ROBERTSON, Jason W. CHIN
  • Publication number: 20240117295
    Abstract: The invention relates to prokaryotic cells for the production of polymers containing non-canonical amino acids, and to methods for making said cells. The invention also relates to newly obtainable polymers as produced by the cells of the invention. In addition, the invention relates to new orthogonal aminoacyl-tRNA synthetases (aaRSs) and orthogonal tRNAs, which may be used in pairs and find utility in host cells such as, but not limited to, the prokaryotic cells of the invention.
    Type: Application
    Filed: May 28, 2021
    Publication date: April 11, 2024
    Inventors: Wesley E. ROBERTSON, Louise F. H. FUNKE, Daniel DE LA TORRE, Julius FREDENS, Thomas S. ELLIOTT, Daniel L. DUNKELMANN, Julian C.W. WILLIS, Adam T. BEATTIE, Jason W. CHIN
  • Publication number: 20230392138
    Abstract: The current invention provides a synthetic prokaryotic genome comprising 5 or fewer occurrences of one or more sense codons; and/or a synthetic prokaryotic genome derived from a parent genome, wherein the synthetic prokaryotic genome comprises less than 10%, 5%, 2%, 1%, 0.5%, 0.1% of the occurrences of one or more sense codons, relative to the parent genome; and/or a synthetic prokaryotic genome comprising 100 or more, 200 or more, or 1000 or more genes with no occurrences of one or more sense codons.
    Type: Application
    Filed: May 22, 2023
    Publication date: December 7, 2023
    Inventors: Julius FREDENS, Kaihang WANG, Daniel DE LA TORRE, Louise F. H. FUNKE, Wesley E. ROBERTSON, Jason W. CHIN
  • Patent number: 11667933
    Abstract: The invention relates to a method comprising a) providing a host cell said host cell comprising an episomal replicon, said episomal replicon comprising a donor nucleic acid sequence, said host cell further comprising a target nucleic acid, b) providing helper protein(s) capable of supporting nucleic acid recombination in said host cell c) providing helper protein(s) and/or RNAs capable of supporting nucleic acid excision in said host cell wherein said donor nucleic acid sequence comprises in order. 5?-homologous recombination sequence 1-sequence of interest-homologous recombination sequence 2-3? wherein said sequence of interest comprises a positive selectable marker d) inducing excision of said donor nucleic acid sequence e) incubating to allow recombination between the excised donor nucleic acid and said target nucleic acid f) selecting for recombinants having incorporated said donor nucleic acid into said target nucleic acid. Also described are nucleic acids and cells.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: June 6, 2023
    Inventors: Julius Fredens, Kaihang Wang, Jason W. Chin
  • Publication number: 20220282241
    Abstract: The current invention provides a synthetic prokaryotic genome comprising 5 or fewer occurrences of one or more sense codons; and/or a synthetic prokaryotic genome derived from a parent genome, wherein the synthetic prokaryotic genome comprises less than 10%, 5%, 2%, 1%, 0.5%, 0.1% of the occurrences of one or more sense codons, relative to the parent genome; and/or a synthetic prokaryotic genome comprising 100 or more, 200 or more, or 1000 or more genes with no occurrences of one or more sense codons.
    Type: Application
    Filed: May 14, 2020
    Publication date: September 8, 2022
    Inventors: Julius FREDENS, Kaihang WANG, Daniel DE LA TORRE, Louise F. H. FUNKE, Wesley E. ROBERTSON, Jason W. CHIN
  • Publication number: 20200063164
    Abstract: The invention relates to a method comprising a) providing a host cell said host cell comprising an episomal replicon, said episomal replicon comprising a donor nucleic acid sequence, said host cell further comprising a target nucleic acid, b) providing helper protein(s) capable of supporting nucleic acid recombination in said host cell c) providing helper protein(s) and/or RNAs capable of supporting nucleic acid excision in said host cell wherein said donor nucleic acid sequence comprises in order: 5?-homologous recombination sequence 1-sequence of interest-homologous recombination sequence 2-3? wherein said sequence of interest comprises a positive selectable marker d) inducing excision of said donor nucleic acid sequence e) incubating to allow recombination between the excised donor nucleic acid and said target nucleic acid f) selecting for recombinants having incorporated said donor nucleic acid into said target nucleic acid. Also described are nucleic acids and cells.
    Type: Application
    Filed: July 27, 2017
    Publication date: February 27, 2020
    Inventors: Julius FREDENS, Kaihang WANG, Jason W. CHIN